PT98105A - Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano - Google Patents

Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano

Info

Publication number
PT98105A
PT98105A PT98105A PT9810591A PT98105A PT 98105 A PT98105 A PT 98105A PT 98105 A PT98105 A PT 98105A PT 9810591 A PT9810591 A PT 9810591A PT 98105 A PT98105 A PT 98105A
Authority
PT
Portugal
Prior art keywords
tetrafluoroethane
formulations
propulsor
preparation
aerosol containing
Prior art date
Application number
PT98105A
Other languages
English (en)
Other versions
PT98105B (pt
Inventor
Keith Arthur Johnson
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/649,405 external-priority patent/US5126123A/en
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of PT98105A publication Critical patent/PT98105A/pt
Publication of PT98105B publication Critical patent/PT98105B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98105A 1990-06-28 1991-06-27 Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano PT98105B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54543790A 1990-06-28 1990-06-28
US07/649,405 US5126123A (en) 1990-06-28 1991-02-01 Aerosol drug formulations

Publications (2)

Publication Number Publication Date
PT98105A true PT98105A (pt) 1993-08-31
PT98105B PT98105B (pt) 1998-11-30

Family

ID=27067939

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98105A PT98105B (pt) 1990-06-28 1991-06-27 Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano

Country Status (13)

Country Link
EP (1) EP0536250B1 (pt)
JP (1) JP3056784B2 (pt)
AT (1) ATE196076T1 (pt)
AU (1) AU649702B2 (pt)
CA (1) CA2083821A1 (pt)
DE (1) DE69132407T2 (pt)
ES (1) ES2151476T3 (pt)
GB (1) GB2263064B (pt)
IE (1) IE912246A1 (pt)
IL (1) IL98639A0 (pt)
NZ (1) NZ238749A (pt)
PT (1) PT98105B (pt)
WO (1) WO1992000107A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
EP0518601A1 (en) 1991-06-10 1992-12-16 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
EP0616525B1 (en) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmaceutical aerosol formulation
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
GB9202522D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
CA2125666C (en) 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
EP0731688B1 (en) * 1993-12-02 2003-03-05 Abbott Laboratories Aerosol drug formulations for use with non-cfc propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9626960D0 (en) 1996-12-27 1997-02-12 Glaxo Group Ltd Valve for aerosol container
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7905230B2 (en) 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ATE320795T1 (de) * 2001-08-03 2006-04-15 Glaxo Group Ltd Oberflächenaktive verbindungen und ihre anwendungen
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
MX2007014531A (es) 2005-05-18 2008-04-29 Nektar Therapeutics Valvulas, dispositivos y metodos para terapia endobronquial.
BRPI0616642A2 (pt) 2005-09-29 2011-06-28 Nektar Therapeutics formulações de antibióticos, doses unitárias, kits e métodos
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
WO2010033240A2 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
US20210244896A1 (en) * 2018-06-13 2021-08-12 Puff-Ah Pty Ltd Apparatus for use in delivering respiratory drugs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
WO1991014422A1 (en) * 1990-03-23 1991-10-03 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
FR2660297B1 (fr) * 1990-03-30 1992-06-12 Coflexip Dispositif de suspension et dispositif de liaison comportant un tel dispositif de suspension.
WO1992000062A1 (en) * 1990-06-27 1992-01-09 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations

Also Published As

Publication number Publication date
JP3056784B2 (ja) 2000-06-26
GB9223891D0 (en) 1993-04-21
EP0536250A4 (en) 1993-06-16
GB2263064A (en) 1993-07-14
IE912246A1 (en) 1992-01-01
WO1992000107A1 (en) 1992-01-09
AU649702B2 (en) 1994-06-02
DE69132407T2 (de) 2001-04-05
PT98105B (pt) 1998-11-30
DE69132407D1 (de) 2000-10-12
CA2083821A1 (en) 1991-12-29
JPH05507935A (ja) 1993-11-11
ATE196076T1 (de) 2000-09-15
EP0536250B1 (en) 2000-09-06
EP0536250A1 (en) 1993-04-14
NZ238749A (en) 1993-07-27
GB2263064B (en) 1994-09-14
ES2151476T3 (es) 2001-01-01
AU8213591A (en) 1992-01-23
IL98639A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
PT98105A (pt) Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
EP0995434A3 (en) Medicinal aerosol formulations
IE800117L (en) Depot body on the basis of silicone rubber for sustained¹drug release
IL77467A (en) Drug-containing aerosol formulations comprising chlorofluorocarbon propellent
EP0636362A3 (en) Use of soluble fluorinated surfactants in the preparation of compositions for metered-dose aerosol.
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
HUT41951A (en) Process for producing insecticide compositions containing fluorinated ethers as active agents and process for producing the active agents
HUT44414A (en) Pesticide comprising 1,2,3,6 tetrahydro-5-nitropyrimidine derivatives as active substance and process for preparing the active substance
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
PH21102A (en) Improvements in or relating to benzothiophene derivatives as antiastmatic agents
ES509798A0 (es) Procedimiento para la obtencion de lapices antimicoticos con mayor liberacion de sustancia activa.
AU6924698A (en) Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
HUT49596A (en) Herbicides comprising iminophenylthiazolidine derivatives as actie ingredient and process for producing the active ingredients
ES2060293T3 (es) Nueva sustancia antiulcerosa.
GB2021409A (en) Pharmaceutical composition
CA2003213A1 (en) Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
IT8919975A0 (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
HUT61561A (en) Process for producing octadecyl-/2-(n-methylpiperidino)-ethyl/-phosphate and pharmaceutical compositions comprising same as active ingredient
GB2037289B (en) Nucleoside derivatives and an antileukemial agent containing the same as an active ingredient
HUT48207A (en) Herbicide comprising oximino ether compounds and process for producing the active ingredients
HUT46881A (en) Herbicides comprising cyclohexane-1,3,5-triones as active ingredient and process for producing the active ingredients
HUT47397A (en) Herbicides comprising sulfonyl-amino-guanidino-azine derivatives as active ingredient and process for producing the active ingredients

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930415

FG3A Patent granted, date of granting

Effective date: 19980825

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20100225